Ms. Denise Kwiatkowski
Regulatory Affairs Manager
Scientific Protein Laboratories, LLC
700 East Main Street
Waunakee , WI 53597
United StatesFEI 2111173Issued Oct 10, 2025Center for Drug Evaluation and Research (CDER)
Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 2111173.
Violations1
Issue DateOct 10, 2025
Product TypeDrugs
StatusOpen
Letter Details
Firm
Scientific Protein Laboratories, LLC
Location
Ms. Denise Kwiatkowski
Regulatory Affairs Manager
Scientific Protein Laboratories, LLC
700 East Main Street
Waunakee , WI 53597
United States
FEI Number
2111173
Country
United States
Issue Date
October 10, 2025
Issuing Office
Center for Drug Evaluation and Research (CDER)
Product Type
Drugs
Status
Open
Summary
Scientific Protein Laboratories, LLC received a warning letter for manufacturing adulterated active pharmaceutical ingredients (APIs) that failed to meet Current Good Manufacturing Practice (CGMP) standards. During an April-May 2025 inspection of their Waunakee, Wisconsin facility, FDA investigators identified significant equipment deficiencies, specifically observing grooves and scratches on API contact surfaces of manufacturing tables used in pancrelipase production, which could contaminate the API with particulate matter and compromise product quality. The company had failed to ensure that equipment surfaces in contact with raw materials and APIs maintained specifications and did not alter product quality. While the company responded with corrective actions including equipment servicing, inspection, and replacement, the violations indicated systemic control failures in their manufacturing processes.
Scientific Protein Laboratories, LLC FDA Warning Letter, October 10, 2025